Drug Profile
Tadalafil topical - Callitas Therapeutics
Alternative Names: ExtrinsaLatest Information Update: 01 Jan 2022
Price :
$50
*
At a glance
- Originator Callitas Therapeutics
- Class Antihypertensives; Benzodioxoles; Carbolines; Erectile dysfunction therapies; Gastrokinetics; Heart failure therapies; Indoles; Ischaemic heart disorder therapies; Pyridones; Small molecules; Vascular disorder therapies; Vasodilators
- Mechanism of Action Type 5 cyclic nucleotide phosphodiesterase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Female sexual dysfunction
Most Recent Events
- 28 Aug 2021 No recent reports of development identified for preclinical development in Female-sexual-dysfunction in USA (Topical)
- 18 May 2021 Camargo Pharmaceutical Services has been acquired by Premier Research Group
- 14 Aug 2018 Chemical structure information added